Clyra Medical Technologies Appoints Douglas Morgan as COO for Growth and Innovation

Clyra Medical Technologies has appointed Douglas Morgan as its new Chief Operating Officer. Morgan, who has a rich history of executive leadership in sectors such as biomedical, software, mobile, and security, will play a pivotal role in enhancing Clyra's operational strategies. His prior roles include CEO at Performance Strategies and contributions to intellectual property strategy, with over a dozen U.S. patents. Mr. Morgan's extensive academic credentials, including a summa cum laude degree from MIT and a Master’s from Stanford University, underpin his capacity to innovate at Clyra. At Clyra, he will be responsible for leading production, supply chain optimization, and strategic partnerships in Regulatory, Clinical Affairs, and Product Development. Clyra Medical Technologies is focused on developing advanced wound care solutions that integrate antimicrobial technologies to improve patient care.